Navigation Links
Differences between women and men with a primary psychotic episode analyzed in a Ph.D. thesis

This release is available in Spanish.

Schizophrenia is a heterogeneous disease, due to the fact that the reasons for its onset are varied, as are the reactions of patients who suffer from it. Some experts relieve that gender is an important factor in this heterogeneity. Ms Ana Cataln has presented her PhD thesis at the University of the Basque Country (UPV/EHU) on this topic, entitled Differences in the prognostic and clinical presentation as a function of gender amongst patients with a primary psychotic episode. She concluded that there are differences between men and women in this matter and that should be taken into account, but there is no evidence to suggest that sex totally conditions this illness.

In order to carry out her thesis, Ms Cataln designed an observational study and limited it to the primary psychotic episode. She analysed 231 patients, selected after establishing the criteria required thereof. For two years she studied the progress of these patients with a primary psychotic episode, evaluating gender solely as a biological feature, i.e. leaving aside its social and cultural connotations.

Later in women

Based on the observation of these patients, according to Ms Cataln, women with a primary psychotic episode in general show symptoms of the illness later and have a greater probability of being married and/or living with their partner and/or children. Moreover, in the case of women it is more common to suffer an acute form of psychosocial stress in the year prior to the onset of the illness. Also, on applying the Cannon-Spoor subscale, which measures the promorbid or prior to the illness adjustment, women obtain better results in late adolescence, adult age and in general. That is, during the lifetime previous to the onset of the first symptoms, appropriately complying with expectations in accord with each age range.

The author of the thesis also used the scale known as PANSS in order to analyse the clinical progress of the patients over the two years the research lasted; this scale is used to measure the gravity of the symptoms of patients with schizophrenia. As the scale shows, differences between the two sexes are, with an occasional exception, scant in the progress at the basal phase of the illness.

Thus, concluded Ms Cataln, the sex does not turn out to be a decisive prognostic factor in the progress of primary psychotic episodes. However, there are differences produced between men and women as regards the characteristics of the psychotic crisis episodes (clinical phenotype) and the author of the thesis underlines that these should be taken into consideration by the doctor.


Contact: Amaia Portugal
Elhuyar Fundazioa

Related medicine news :

1. Chinese systemic lupus erythematosus data reveal differences in epidemiology across continents
2. Genealogy may affect clinical differences in systemic lupus erythmatosus patients
3. Vast geographic differences found in drug spending under Medicare
4. Survey highlights major Canada-US differences in people in middle age
5. Genetic differences may influence joint pain among women taking lifesaving breast cancer drugs
6. Regional differences in C-section rate not a result of maternal request: UBC study
7. Dyslexia Linked to Differences in Brain Circuitry
8. Population health plays a bigger role in geographic differences in Medicare spending
9. Exploring gender differences in colorectal cancer screenings
10. Differences in language circuits in the brain linked to dyslexia
11. Gender Differences Show in Risk of Narcotic Abuse
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology: